11 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... Antimicrobials #Empiric #Coverage ... #InfectiousDiseases ... #Pharmacology #
Antibiotics - Spectrum and Coverage Antibiogram

#Antibiogram #Antibiotics #Classes #Bacterial #Spectrum #Coverage #Susceptibility #Susceptibilities #InfectiousDiseases #Pharmacology
- Spectrum and Coverage ... Bacterial #Spectrum #Coverage ... Susceptibilities #InfectiousDiseases ... #Pharmacology
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Empiric Treatment Options ... Staphylococcus aureus Coverage ... /Gram-Negative Coverage ... Appropriate #Management #InfectiousDiseases
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
#IDSA #Meningitis ... Pathogens #Isolated #InfectiousDiseases ... #Pharmacology #
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
Coverage of common ... For empiric coverage ... #management #infectiousdisease ... #antibiotics #coverage ... #antibiogram #pharmacology
Acyclovir - Pharmacology Summary

 • Mechanism of Action: Nucleoside analog - selectively inhibits viral replication of
Acyclovir - Pharmacology ... Antimicrobial Spectrum of Coverage ... #Acyclovir #Pharmacology ... #InfectiousDiseases
Antifungal Coverage Activity Antibiogram 

Spectrum of action of systemic antifungal agents. Solid blocks represent species in
Antifungal Coverage ... Antifungal #Spectrum #Coverage ... Echinocandins #Pharmacology ... #InfectiousDiseases
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
fluconazole; ISA ... antibiogram #management #pharmacology ... #spectrum #coverage
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... 6: If limited options ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
ClostridiumDifficile #options ... treatment #management #pharmacology ... #idsa #table